Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - SHORT-TERM INVESTMENTS
Short-term Investments ALNY - Alnylam Pharmaceuticals, Inc.
1.73 B
LAST VALUE
14.16%
2 YEAR CAGR
11.81%
5 YEAR CAGR
33.71%
10 YEAR CAGR